This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Orapi: takeover bid reopens on February 12 CF
Orapi: 3.15 million shares tendered to the takeover bid CF
Orapi: takeover bid opens on December 27 CF
PCAS: 200 ME capital increase CF
PCAS: OPAS to start this Friday CF
PCAS Announces the Consolidated Net Sales Results for the Month of September 30, 2023 CI
Progyny, Inc. : Want to have a baby? Our Logo
PCAS: Seqens launches minority share offer CF
PCAS SA Reports Earnings Results for the Half Year Ended June 30, 2023 CI
PCAS SA Reports Consolidated Sales Results for the Period Ended June 30, 2023 CI
DIC Corporation completed the acquisition of PCAS Canada Inc. from PCAS SA. CI
PCAS: sale of Canadian subsidiary confirmed CF
PCAS to Divest Canadian Arm to Japan's DIC MT
DIC Corporation agreed to acquire PCAS Canada Inc. from PCAS SA for an enterprise value of ?88.2 million. CI
PCAS in Talks to Sell Canada Unit to DIC CI
PCAS: buoyed by offer for Canadian subsidiary CF
France's PCAS Enters Exclusive Talks for Canadian Unit Sale to Japan's DIC MT
PCAS: larger net loss in 2022 CF
Global markets live: Airbus, Manchester United, EA, Credit Suisse, Warner... Our Logo
PCAS SA Reports Earnings Results for the Full Year Ended December 31, 2022 CI
PCAS: 21% increase in sales by 2022 CF
PCAS SA Reports Consolidated Net Sales Results as of December 31, 2022 CI
PCAS CEO Resigns; Acting Successor Named MT
Pcas Sa Announces Executive Changes CI
Pcas Appoints Mr. Jean-Louis Martin as Director CI
Chart PCAS
More charts
PCAS specializes in developing, manufacturing, and marketing fine and specialty chemicals. Sales are distributed by family of products as follows: - synthesized pharmaceutical products (63.5%); - fine chemicals (36.5%): technical fluids and additives for the lubricant industry, chemical additive synthesis. The group also offers photochemical and new technology products (photosensitive materials, photo-initiators, and polymers for photography, reprography, and micro-electronics). At the end of 2022, the group had 7 production sites located in France (5), Canada and Finland. France accounts for 76% of net sales.
More about the company
  1. Stock Market
  2. Equities
  3. PCA Stock
  4. News PCAS
  5. PCAS CEO Resigns; Acting Successor Named